Showing results (341-350 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|March 2, 2022
Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung AdenocarcinomaZimo Zhou, Tiantong Zhu, Senxiang Chen, et al.Current Cancer Drug Targets|May 31, 2019
Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell LymphomaLinqing Zou, Guoqi Song, Siyu Gu, et al.Current Cancer Drug Targets|June 20, 2019
Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging CytoskeletonJun Chen, Demin Jiao, Yu Li, et al.Current Cancer Drug Targets|April 7, 2023
Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysisTianzhuo Wang, Guoshuang Shen, Jinming Li, et al.Current Cancer Drug Targets|March 12, 2015
Review on triggered liposomal drug delivery with a focus on ultrasoundHesham G Moussa, Ana M Martins, Ghaleb A HusseiniCurrent Cancer Drug Targets|April 13, 2021
NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell CarcinomaYi Chen, Lei Yang, Ning Liu, et al.Current Cancer Drug Targets|August 28, 2012
Inhibition of Cdc42-interacting protein 4 (CIP4) impairs osteosarcoma tumor progressionNadezhda V Koshkina, Ge Yang, Eugenie S KleinermanCurrent Cancer Drug Targets|August 10, 2012
Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?Håkon Reikvam, Astrid Olsnes Kittang, Guro Melve, et al.Current Cancer Drug Targets|August 10, 2012
Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospectsMasahito Shimizu, Kenji Imai, Koji Takai, et al.Current Cancer Drug Targets|August 10, 2012
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesYujin Hoshida, Bryan C Fuchs, Kenneth K TanabePageof 187